Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Race/Ethnicity-Specific Associations between Smoking, Serum Leptin, and Abdominal Fat: The Multi-Ethnic Study of Atherosclerosis.

Kianoush S, DeFilippis AP, Rodriguez CJ, Rifai MA, Benjamin EJ, Hall ME, Ouyang P, Allison MA, Blaha MJ.

Ethn Dis. 2018 Oct 18;28(4):531-538. doi: 10.18865/ed.28.4.531. eCollection 2018 Fall.

PMID:
30405297
2.

Accuracy and responses of genomic selection on key traits in apple breeding.

Muranty H, Troggio M, Sadok IB, Rifaï MA, Auwerkerken A, Banchi E, Velasco R, Stevanato P, van de Weg WE, Di Guardo M, Kumar S, Laurens F, Bink MC.

Hortic Res. 2015 Dec 23;2:15060. doi: 10.1038/hortres.2015.60. eCollection 2015.

3.

Verbal De-escalation of the Agitated Patient: Consensus Statement of the American Association for Emergency Psychiatry Project BETA De-escalation Workgroup.

Richmond JS, Berlin JS, Fishkind AB, Holloman GH Jr, Zeller SL, Wilson MP, Rifai MA, Ng AT.

West J Emerg Med. 2012 Feb;13(1):17-25. doi: 10.5811/westjem.2011.9.6864.

4.

Utilizing genomic polymorphisms to personalize hepatitis C therapies.

Rifai MA, Sabouni MA.

Curr Opin Organ Transplant. 2012 Apr;17(2):198-203. doi: 10.1097/MOT.0b013e328351093b. Review.

PMID:
22414802
5.

To screen or not to screen for hepatitis C infection?

Rifai MA.

Psychiatr Serv. 2010 Mar;61(3):325-6; author reply 326-7. doi: 10.1176/ps.2010.61.3.325a. No abstract available.

PMID:
20194415
6.

The influence of antiviral therapy on psychiatric symptoms among patients with hepatitis C and schizophrenia.

Huckans M, Mitchell A, Pavawalla S, Morasco BJ, Ruimy S, Loftis JM, Rifai MA, Hauser P.

Antivir Ther. 2010;15(1):111-9. doi: 10.3851/IMP1493.

7.

Psychiatric care of the patient with hepatitis C: a review of the literature.

Rifai MA, Gleason OC, Sabouni D.

Prim Care Companion J Clin Psychiatry. 2010;12(6). pii: PCC.09r00877. doi: 10.4088/PCC.09r00877whi.

8.

Osteodystrophy and dialysis survival.

Bonne JF, Mailliez S, Rifai MA, Shahapuni I, Mansour J, Fournier A.

Kidney Int. 2007 May;71(9):953; author reply 953-4. No abstract available.

9.

A randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis C.

Morasco BJ, Rifai MA, Loftis JM, Indest DW, Moles JK, Hauser P.

J Affect Disord. 2007 Nov;103(1-3):83-90. Epub 2007 Feb 9. Erratum in: J Affect Disord. 2009 Feb;113(1-2):201.

PMID:
17292481
10.

Hepatitis C treatment of patients with bipolar disorder: a case series.

Rifai MA.

Prim Care Companion J Clin Psychiatry. 2006;8(6):361-6.

11.

Ethical impasses in the care of patients with hepatitis C.

Rifai MA.

Psychosomatics. 2006 Nov-Dec;47(6):540-1. No abstract available.

PMID:
17116963
12.

Psychiatric management of the hepatitis C patient.

Rifai MA, Indest D, Loftis J, Hauser P.

Curr Treat Options Gastroenterol. 2006;9(6):508-19.

PMID:
17081484
13.

Hepatitis C treatment eligibility and outcomes among patients with psychiatric illness.

Rifai MA, Moles JK, Short DD.

Psychiatr Serv. 2006 Apr;57(4):570-2.

PMID:
16603757
14.

Hepatitis C treatment of veterans with psychiatric illness.

Rifai MA, Loftis JM, Hauser P.

Am J Gastroenterol. 2006 Mar;101(3):673-4; author reply 674-5. No abstract available.

PMID:
16542298
15.

Hepatitis C screening and treatment outcomes in patients with substance use/dependence disorders.

Rifai MA, Moles JK, Lehman LP, Van der Linden BJ.

Psychosomatics. 2006 Mar-Apr;47(2):112-21.

PMID:
16508022
16.

Interferon-alpha treatment of patients with Hepatitis C: the role of a comprehensive risk-benefit assessment.

Rifai MA, Loftis JM, Hauser P.

CNS Drugs. 2005;19(8):719-21; author reply 721-2. No abstract available.

PMID:
16097855
17.

The association between viral clearance and depression in patients with hepatitis C receiving interferon-alpha and ribavirin.

Loftis JM, Hauser P, Rifai MA.

Brain Behav Immun. 2005 Jul;19(4):271-2; author reply 273-4. No abstract available.

PMID:
15944066
18.

Interferon-alpha Treatment of Hepatitis C Patients With Psychiatric Illness: Evidence-Based Risk-Benefit Assessment.

Rifai MA.

Prim Care Companion J Clin Psychiatry. 2005;7(2):74-75. No abstract available.

19.

Interferon for hepatitis C patients with psychiatric disorders.

Rifai MA, Bozorg B, Rosenstein DL.

Am J Psychiatry. 2004 Dec;161(12):2331-2; author reply 2332-4. No abstract available.

PMID:
15569919
20.

Psychiatric comorbidity among hepatitis C-positive patients.

Yovtcheva SP, Rifai MA, Moles JK, Van der Linden BJ.

Psychosomatics. 2001 Sep-Oct;42(5):411-5.

PMID:
11739908

Supplemental Content

Loading ...
Support Center